"I can kill a drug if I have to".

Robert Garnick, Scientific Advisor PPHM

And he did just that, designing a trial with an "early look in" when we all know how Bavi worked, slowly.

As to todays Oncologie news, 2 to 3 years before anything and who will share/own Avid and Bavi rights by then?

Not us!

IMO

Hey Vinny, Bavi's dead, nobody cares. Why do you?

You are so right! With stock manipulation by Stafford and gang being the primary mover of share price, trading this would be nuts. This thing could easily be moved by them to $3.50 for 3 months, the same way it went up to $4.25 for a day.

Send Jedd D. Wolchok at MSKCC $2M a year and he will tell you anything you would like to hear about Bavi. Toss in another $1M and he might even send some work for Avid.

"For why John Spring Stafford sold at $40 Xencor stock"

You should also add he sold $10M worth of stock. How about this. Here is an article dated JANUARY 21, 2019

"Have Insiders Been Selling Xencor, Inc. (NASDAQ:XNCR) Shares This Year?
Simply Wall St. January 21, 2019"

https://finance.yahoo.com/news/insiders-selling-xencor-inc-nasdaq-111200201.html

and now we have an article dated FEBRUARY 21, 2019

"FDA halts Xencor’s study of XmAb14045 following deaths"

https://www.pharmaceutical-technology.com/news/xencor-study-halted-xmab14045-acute-myeloid-leukaemia/

and next we have Johnny buying back all those shares cheaper in MARCH 2019 that you posted.

Even a blind man could figure this one out.

IMO

Excerpts from an article from one of your earlier posts.

“Everyone should know that most cancer research is largely a fraud.” (Dr. Linus Pauling 1986, Nobel Laureate)"

"Why is the Cancer Factory so Powerful?"

"Dr. Gonzalez, the developer of pancreatic enzyme therapy for cancer gives us this answer. “War on cancer” has been a failure due to a combination of politics, money, greed, and corruption—largely the result of an unholy alliance between the American Cancer Society, NCI [National Cancer Institute], Sloan-Kettering, and the drug companies.” [2]"

“The American Cancer Society is more interested in accumulating wealth than saving lives.” (Chronicles of Philanthropy 1992)

“Breast Cancer Awareness Month was actually initiated by the companies that make Tamoxifen. The devices for mammograms are made by General Electric and General Electric is in a relationship with the people behind Breast Cancer Awareness Month, so there is a huge industry that is invested in breast cancer. Although the goal is noble, to me it is obscene that these companies are using the symbol of the pink ribbon for commercial purposes only. Very few dollars ever make it to really help women.” (Dr. Sherrill Sellman, author of What Women MUST Know to Protect their Daughters from Breast Cancer.)"

http://healthimpactnews.com/2014/the-cancer-industry-is-too-prosperous-to-allow-a-cure/

Since 2003....How about you?

"So why do you think Stafford wanted to split off the IP at Peregrine?"

IP was shelved so whichever company picks up Avid on the cheap gets the rights to the IP. If you recall the the other company that licensed their IP to Oncologie not long ago reclaimed it. "IF" the IP actually has value as some here still believe it does, this could be one possible explanation.

"For why John Spring Stafford sold at $40 Xencor stock .... Maybe because he wanted to buy back at $30"

You just posted the following, what do you think?

Filing Date Name/Title Shares Transaction Value
05/02/19
Ronin Capital LLC
14,611 Acquisition at $29.87 per share 436,431
03/25/19
Ronin Capital LLC
3,500 Acquisition at $29.77 per share 104,195
03/22/19
Ronin Capital LLC
2,000 Acquisition at $29.96 per share 59,920
03/18/19
Ronin Capital LLC
1,100 Acquisition at $29.90 per share 32,890
03/15/19
Ronin Capital LLC
38,300 Acquisition at $29.02 per share 1,111,466

"The question now is INmunebio ties to Xencor and John Stafford"

I have reached the point where I believe that biotechs are one of the biggest SCAMS going to make wealthy criminals like Stafford a lot of money without any fear of any form of punishment other than having to pay a fine which requires paying back half the money you've stolen and you get to keep the rest and you get to do this over and over, again and again. It seems to me, just a little bit of science goes a long way, to making millions and millions of dollars for individuals like Stafford or Steven King for that matter, with only a FEW being made examples of for the fraud that goes on.

IMO

"Stafford left Xencor just for legal reasons to go after Peregrine?"

Actually Stafford left Xencor's BOD because he and other BOD members were sued by Xencor shareholders for cooking the Xencor books for their own personal gain. Just before a verdict was reached on the side of the Xencor shareholders he left.

https://www.strategicclaims.net/wp-content/uploads/2017/01/XencorNoticeClaim.pdf

Stafford's decision to leave prior to ruling against him and other Board members.

https://www.prnewswire.com/news-releases/xencor-announces-change-to-board-of-directors-300201814.html

And on to 2019. Stafford is at it again..........

Xencor Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by John Stafford for US$10.0m worth of shares, at about US$40.05 per share. So what is clear is that an insider saw fit to sell at around the current price of US$33.64. They might be selling for a variety of reasons, but it’s hard to argue this is a bullish sign. Arguably, insider selling at around current prices should give us reason to reflect on whether the stock is fully valued at the moment.

In the last twelve months insiders netted US$21m for 526.00k shares sold. Over the last year we saw more insider selling of Xencor shares, than buying. They sold for an average price of about US$40.26. We don’t gain much confidence from insider selling near the recent share price.

https://finance.yahoo.com/news/insiders-selling-xencor-inc-nasdaq-111200201.html

Amen to that!

It seems fly.on.the.wall has some competition....


The "Parking Lot Stalker Report".

"If Ronin didn't...........?"

How about this concept? If Johnny Stafford and his stock manipulating hedge funds hadn't butchered our share price for their own personal gain over the years maybe we wouldn't be where we are today? How many of those reverse splits in reality were created by the likes of him? It's real easy to point ones finger at one group for all our misfortunes but the problem is way deeper than that.

There is no part of me that believes the Chicago Stafford's got into this to save our asses or that Johnny saw any real value in this company that would make him want to do so.

So where is Ronin now, nowhere to found. So what does that tell you?

AIMO

" but things should ramp up imo.. perhaps second half 2019"

Why is it they are always "ramping up" for some time in the future that never comes? That carrot has been dangled on this message board for over 10 years now.

"so glad ronin cleaned house.. "

Yea, with the $3.50 share price I feel like i've died and gone to heaven.

Not to worry, with the house now clean Johnny Stafford can hang the FORECLOSURE sign on it.

IMO

"I would never take 5.50."

You say that as if you think you are actually going to get a choice. Yes, there will be FOR/AGAINST form and you will get to check a box AGAINST but Stafford has more then enough votes with his parked Sheehe shares, Tappan shares, his and Little Stevie White's sub having to report shares, to sell this company at any price he likes which probably isn't even $5.50. The BOD will approve it, all the people hiding under rocks, like King, will re-emerge and find new jobs and the scam that the bio pharmaceutical industry is will go on forever and ever.

End of story!

"we seem to be dead money regardless of institutional ownership !! "

Wow, sounds like something I recently said.

"and go ahead, keep believing Institutional holdings actually mean something."

from westjitter post........

"Where is Steve White now? Ronin? Hopefully we get some clarity soon."

and my answer to that.......

"Who will be the Stafford "process server" to PPHM/Avid shareholders when they tell you they have a buyer for the company at $5.50 a share? Brian L Sheehe or the Tappan Boys?" (now revised to $5 based on Janney downgrade)


WHAT PUBLIC COMPANY HAS A CEO LEAVE AND NOT COME OUT FOR IT'S SHAREHOLDERS WITH A STATEMENT?

One that doesn't give a sh** .................!

and this is how it probably went down....

The phone call:

Hey Roger, it's Johnny, it's time to go. With the market tanking your quick departure will give us just what we need. Before year end this company will be no more. We hope you are happy with your compensation package and would like to thank you for your participation.

Roger...It's been my pleasure, any future projects just let me know.

A Johnny Stafford refresher from another board........


fd_rox Sunday, 10/29/17 01:52:59 PM
Re: None 0
Post # of 106
Goose is the nickname given to John Stafford in recognition to an old tradition at his fraternity at Davidson College. Each year they would bludgeon a goose to death, they eventually lost their Davidson chapter.

If you look into Stafford's other board's that he has been apart of you will see a sea rise of law suits that allege he misuses his inside advantage at the expense of his fellow shareholders. Study his personality and past behavior, he likes to bludgeon shareholders like the old goose tradition.

Look into :
1)the sale of an options trading firm to TD Bank - multiple law suits
2) sale of the Unbreakable Lock Company
3) secondary offering for Xencor Inc (XNCR)
4) sold Aware (AWRE) IP for a song

Study who you are dealing with. Long history here of poor treatment of shareholders both in and outside of Aware Inc.

You are obviously new and nieve to this company.

Well, "Roger Dodger" bails. He certainly "hit the ground running".

Is Tracey next? Did I hit a nerve?

What does Roger know we don't? What is it Roger doesn't want to be part of? He "left for personal reasons", what a crock of BS...........are you kidding me?

Who will be the Stafford "process server" to PPHM/Avid shareholders when they tell you they have a buyer for the company at $5.50 a share?

Brian L Sheehe or the Tappan Boys? They both want to kiss the Stafford ring!

The PPHM/CDMO story is soon to be buried and all it's dirty little secrets with it.........

and go ahead keep believing Institutional holdings actually mean something. Ronin, samurai, chop their heads off, what don't you people get? The Chicago branch of the Stafford family, this is what they live to do.

Not only do you get free wading boots and a shovel with each CDMO share you also get a can of white paint.

AIMO

"Sinking to new lows"?

We have found ourselves in a situation where "cancer research" was/ is being used to bilk individuals, in our case, pphm/cdmo shareholders and so many others of their money. With major research centers like MSKCC and Duke involved, cancer research LIVES only for the money it generates and quite frankly doesn't care if you DIE from cancer IMO. The history and trail of deceit is so deep that all these individuals and institutions, like UTSW need to be questioned and make public as to what is really going on. Stafford was brought in to squash what was happening at PPHM because it can't be made public.

I say "vote the black card" and waterboard King for the truth because otherwise you are never going to get it.

I owe these people NOTHING.........they stole my money......and what I say about them is what THEY get in return.

"Let’s hope Tracy’s credibility can be upheld."

You may remember, who said "Roger "Dodger" is doing Tracey which is why he said, "she hit the ground running"?

"We're all frustrated mostly with the lack of uplisting."

Class Action Lawsuits = No Nasdaq Up-listing

Folks here can spin it every which way they want but that's it plain and simple.

These class actions didn't happen because someone lost money. They happened to slow the company down.

Down .50 on 40/shares....will Clay Pidgeon show up next!

"Enjoy seeing Stafford squirm."

And why is it Stafford is squirming? He has a $300M personal portfolio. He's wouldn't care about 350K shares he purportedly has in this Genmark Diagnostics company that might have been in competition with PPHM's exosome blood test, total nonsense IMO. Phone calls were made from Stafford Capital Partners to the Chicago Stafford's to shut PPHM down. Cancer research funding with so many ties to big business, BP's, stock market hedge fund manipulations, little biotechs, the whole thing was coming unhinged. Memorial Sloan Kettering news about too much graft with researchers like Wolchock and pharmas was all part of it. MSL came clean before ALL the truth might come out. PPHM was just a pimple paying MSL $2M a year to keep the "dream" alive. Cancer research in this country is a $5 billion dollar a year BUSINESS. King got to greedy and with notable people like Rob Garnick and all these top researchers behind PPHM, ties to UTSW big money was probably getting nervous. PPHM was just part of the truth they didn't want to come out and all of the dirty dealing going on and because of that it needed to be eliminated.

https://www.staffordcp.com/founding-partners ..............Austin, Texas

Top Cancer Hospitals for 2018-19
University of Texas MD Anderson Cancer Center.
Memorial Sloan-Kettering Cancer Center.
Mayo Clinic.
Dana-Farber/Brigham and Women's Cancer Center.
Cleveland Clinic.
Johns Hopkins Hospital.
Seattle Cancer Alliance/University of Wa

IMO

"Making you laugh is not relevant."

After reading the most recent posts are you sure?

"a honest current value on CDMO and why."

And in that statement lies your biggest mistake........

"HONEST"

Don't make me laugh.

IMO

"New bussiness must be in place."

LMAO

"We are not artificially low."

Absolutely right, it's not "artificial", we have been PURPOSELY made low so "cheap options can be granted". This place should be on one of those stand up comedy shows.

Actually maybe you got it right "NEW BUSSINESS........."

Yea, they are busy as bees over there in Tustin.

My source tell's me the new elevator is for the "VIP LOUNGE WITH SPECIAL LIGHTING!" The plan is to serve Nathans Famous Hot dogs with dijon mustard so Brian L. Sheehe can groove out and try and recoup some of his CDMO investment loss. With every hot dog purchase you get one share of CDMO.

Always some excuse! Stafford, White, Tappan, all these hedge funds maintain long and short positions to MANIPULATE THE STOCK and can make the SP anything they want it to be at any given time and you can be sure of one thing, they never get burned.

Stafford was the facilitator. He never gave a rats ass about this company or its shareholders. He is probably sorry for getting involved for all the times his name has come up here.

"Who do we know that knows the Company pretty well and is versed in shorting ?"

" In addition, we also reduce our net exposure through our short positions. While we aren’t suggesting that you can’t lose money on shorts, we do believe they will help insulate the portfolio during market dislocations; moreover, we think there is a lot of opportunity for a fund of our size to generate returns on shorts even absent market selloffs."

Prasad Phatak and Chris Koranda of Tappan Street Partners

http://www.distressed-debt-investing.com/2013/04/emerging-manager-interview-series.html

September 11, 2017 at 8:05 AM EDT

PEREGRINE PHARMACEUTICALS ANNOUNCES APPOINTMENT OF ROGER J. LIAS, PH.D. AS PRESIDENT OF AVID BIOSERVICES

"Steven King will step down from his role as president of Avid on September 25, 2017 and remain as president and chief executive officer of Peregrine."

Woodstock...... : )

That's an amazing truck!

"the construction near Avid has nothing to do with Avid"

With weed being practically legal in California I can understand the confusion that might occur from stalking parking lots there.

In light of who you are don't you find it the least bit disturbing that you would come on this message board looking for answers? Stafford had McComb get out at $6.50 which to me indicates a buy out offer sub that number. I still think Brian L. Sheehe (ISZO former/current Wells Fargo) is parking stocks for Stafford. He will turn activist per Stafford and propose a buyout offer sub $6.50 to some prearranged entity prior to ASM. Then everyone can kiss the whole ball of wax goodbye!

IMO

"You honestly think Dr. Jedd Wolchok would have put his name on the line for something that does not work?"

Pay Jed some money and he will put his name on whatever you like.

Sloan Kettering Researchers Correct the Record by Revealing Company Ties

https://www.nytimes.com/2018/10/12/health/memorial-sloan-kettering-cancer-disclosure.html

"Dr. Jedd Wolchok, an oncologist specializing in immunotherapy at Memorial Sloan Kettering Cancer Center, revealed ties to 31 companies in correcting disclosures for research articles,
Credit Andrew Renneisen for The New York Times"

" Dr. Jedd Wolchok, a noted pioneer in immunotherapy, has financial relationships with more than 30 companies, according to recent disclosures. Dr. Charles L. Sawyers, another of the hospital’s biggest names, has founded several cancer start-ups, one of which Memorial Sloan Kettering has invested in, and serves on the board of the Swiss pharmaceutical giant Novartis.

Ethicists and health experts say having leaders and researchers at nonprofit hospitals sit on corporate boards is especially problematic. When they serve on the board of a publicly traded company, they have a legal duty to the corporation and its shareholders, which can clash with their duty to their patients and primary employers. Those who sit on boards are often paid hundreds of thousands of dollars a year."

They should have titled the article, "THE GRAND SCAM"

By the time we reach the next ASM the SP will still be $4. Brian L. Sheehe will turn activist and present a letter actually composed by Stafford & White. The letter will suggest the sale of this worthless company to Halo for $6. Sheehe and Tappan will vote all the shares they have been parking for Stafford & White and with Stafford & White's unknown number of shares will have a majority vote that the BOD will approve the sale. Oncologie will return Bavi to Halo the new owners and develop it into a viable product. Steven King will be hired by Stafford as a financial advisor and eventually marry what's her face from Fargo, North Dakota who's now working for Blackrock and PPHM/CDMO shareholders will get, well we know what they get..................!

" i don't think there is any hurry on SP until some of the options are distributed "

Isn't that song getting a little old?

Below is your 7th post on this board.

jakedogman1 Wednesday, 06/07/06 08:56:33 PM
Re: None 0
Post # of 329908
I don't think management wants this to run yet. My guess is they get more options under their belts at a low price.

"Also appears that both Gallus and Brammer from start to sale were 3-4 year deals"

"Over the span of a DECADE, we have successfully completed over 100 projects to supply cell and gene therapy clinical trials. We have supplied more than 150 lots for our clients, many for first-in-human trials."

https://www.brammerbio.com/our-team

It's DECADE as in 10 years.

BRAMMER BIO......300,000 SQUARE FEET which they own.

"We are a team of over 500 professionals who operate over 300,000 SQUARE-FEET of bio process development and manufacturing space.

Over the span of a decade, we have successfully completed over 100 projects to supply cell and gene therapy clinical trials. We have supplied more than 150 lots for our clients, many for first-in-human trials. We develop customized solutions for clients’ breakthrough therapeutics and are ready to support clients through licensure and commercial supply. The Brammer team consists of individuals experienced in a broad range of disciplines."

https://www.brammerbio.com/our-team

"Mark R. Bamforth

President and Chief Executive Officer, Founder

In 2015 Mark founded Brammer Biopharmaceuticals, a cell and gene therapy CMO, subsequently merged in March 2016 with Florida Biologix to create Brammer Bio."

Brammer Bio provides a complete range of development, and early phase to commercial GMP manufacturing services for gene therapies using multiple platform technologies.

Our services are comprehensive. They include pre-clinical process and analytical development, process optimization, process scale-up, process and analytical qualification, clinical and commercial supply of drug substances and formulated drug products. We also provide logistics and warehousing support for in-bound and out-bound materials.

Our standards are high. From initial inquiry through development, manufacturing, testing and product release, quality is paramount. Our in-house quality and validation teams provide a full range of assay development, analytical services, facility and systems set up and monitoring, product review and
regulatory support.

Flexibility is at our core. The design of our multi-product facilities and use of single use equipment allows maximum flexibility for project scheduling while ensuring product quality. We strive to exceed expectations. Our collaborative approach ensures that our clients are engaged and well informed throughout the project.

Compliance is key. Brammer’s facilities are designed to be compliant for viral vector-based gene therapy products under the FDA Code of Federal Regulations (Part 21) and the European Advanced Therapy Medicinal Products’ regulations.

That first trade was just our activist shareholder parking his stocks in another account so he doesn't have to report on his manipulation of the share price.

IMO